The transcription factor DEC1 (BHLHE40/STRA13/SHARP-2) is negatively associated with TNM stage in non-small-cell lung cancer and inhibits the proliferation through cyclin D1 in A549 and BE1 cells

Tumor Biology

Volumn 34, Issue 3, 2013, Pages 1641-1650

  Liu, Yang ^a   Wang, Liang ^a   Lin, Xu Yong ^a   Wang, Jian ^a   Yu, Juan Han ^a   Miao, Yuan ^a   Wang, En Hua ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Cyclin D1; Differentiated embryo chondrocyte expressed gene 1; Immunohistochemistry; Non small cell lung cancer; Proliferation

Indexed keywords

CYCLIN D1; DIFFERENTIATED EMBRYO CHONDROCYTE EXPRESSED GENE 1; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; UPREGULATION;

EID: 84878697661     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0697-z     Document Type: Article

References (37)

1. Travis WD. Pathology of lung cancer. Clin Chest Med. 2011;32:669-92.
2. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small cell lung cancer collaborative group. BMJ 1995;311:899-909
3. O'Mahony D, Kummar S, Gutierrez ME. Non-small-cell lung cancer vaccine therapy: a concise review. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23:9022-8.
4. Shepherd FA, Rodrigues Pereira J, Ciuleanu T, Tan EH, Hirsh V, Thongprasert S, et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med. 2005;353:123-32.
5. Tsao MS, Sakurada A, Cutz JC, Zhu CQ, Kamel-Reid S, Squire J, et al. Erlotinib in lung cancer - molecular and clinical predictors of outcome. N Engl J Med. 2005;353:133-44.
6. Zhang YA, Nemunaitis J, Samuel SK, Chen P, Shen Y, Tong AW. Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA. Cancer Res. 2006;66:9736-43.
7. Boudjelal M, Taneja R, Matsubara S, Bouillet P, Dolle P, Chambon P. Overexpression of stra13, a novel retinoic acid-inducible gene of the basic helix-loop-helix family, inhibits mesodermal and promotes neuronal differentiation of p19 cells. Genes Dev. 1997;11:2052-65.
8. Shen M, Kawamoto T, Yan W, Nakamasu K, Tamagami M, Koyano Y, et al. Molecular characterization of the novel basic helix-loop-helix protein DEC1 expressed in differentiated human embryo chondrocytes. Biochem Biophys Res Commun. 1997;236:294-8.
9. Guillaumond F, Lacoche S, Dulong S, Grechez-Cassiau A, Filipski E, Li XM, et al. Altered STRA13 and DEC2 circadian gene expression in hypoxic cells. Biochem Biophys Res Commun. 2008;369:1184-9.
10. Qian Y, Zhang J, Yan B, Chen X. Dec1, a basic helix-loop-helix transcription factor and a novel target gene of the p53 family, mediates p53-dependent premature senescence. J Biol Chem. 2008;283:2896-905.
11. Yamada K, Miyamoto K. Basic helix-loop-helix transcription factors, bhlhb2 and bhlhb3; their gene expressions are regulated by multiple extracellular stimuli. Frontiers in bioscience. A J virtual Libr. 2005;10:3151-71.
12. Ivanova A, Liao SY, Lerman MI, Ivanov S, Stanbridge EJ. Stra13 expression and subcellular localisation in normal and tumour tissues: implications for use as a diagnostic and differentiation marker. J Med Genet. 2005;42:565-76.
13. Turley H, Wykoff CC, Troup S, Watson PH, Gatter KC, Harris AL. The hypoxia-regulated transcription factor dec1 (stra13, sharp-2) and its expression in human tissues and tumours. J Pathol. 2004;203:808-13.
14. Chakrabarti J, Turley H, Campo L, Han C, Harris AL, Gatter KC, et al. The transcription factor dec1 (stra13, sharp2) is associated with the hypoxic response and high tumour grade in human breast cancers. Br J Cancer. 2004;91:954-8.
15. Zheng Y, Jia Y, Wang Y, Wang M, Li B, Shi X, et al. The hypoxia-regulated transcription factor dec1 (stra13, sharp-2) and its expression in gastric cancer. Omics A J Genet Biol. 2009;13:301-6.
16. Li Y, Zhang H, Xie M, Hu M, Ge S, Yang D, et al. Abundant expression of dec1/stra13/sharp2 in colon carcinoma: its antagonizing role in serum deprivation-induced apoptosis and selective inhibition of procaspase activation. Biochem J. 2002;367:413-22.
17. Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Wykoff CC, Gatter KC, et al. Dec1 (stra13) protein expression relates to hypoxia-inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer. J Pathol. 2003;200:222-8.
18. Shi XH, Zheng Y, Sun Q, Cui J, Liu QH, Qu F, et al. Dec1 nuclear expression: a marker of differentiation grade in hepatocellular carcinoma. World J Gastroenterol. 2011;17:2037-43.
19. Wang W, Reiser-Erkan C, Michalski CW, Raggi MC, Quan L, Yupei Z, et al. Hypoxia inducible bhlhb2 is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma. Biochem Biophys Res Commun. 2010;401:422-8.
20. Shi X, Zheng Y, Ma W, Wang Y. Possible involvement of DEC1 on the adverse effects of quinolone antibiotics. Toxicology. 2010;271:1-4.
21. Bhawal UK, Sato F, Arakawa Y, Fujimoto K, Kawamoto T, Tanimoto K, et al. Basic helix-loop-helix transcription factor dec1 negatively regulates cyclin d1. J Pathol. 2011;224:420-9.
22. Zhang L, Li QQ. Embryo-chondrocyte expressed gene 1, downregulating hypoxia-inducible factor 1alpha, is another marker of lung tumor hypoxia. Acta Pharmacol Sin. 2007;28:549-58.
23. Wu Y, Sato F, Yamada T, Bhawal UK, Kawamoto T, Fujimoto K, Noshiro M, Seino H, Morohashi S, Hakamada K, Abiko Y, Kato Y, Kijima H: The bhlh transcription factor dec1 plays an important role in the epithelial-mesenchymal transition of pancreatic cancer. International Journal of Oncology 2012
24. Harbour JW, Dean DC. The rb/e2f pathway: expanding roles and emerging paradigms. Genes Dev. 2000;14:2393-409.
25. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995;81:323-30.
26. Malumbres M, Barbacid M. Cell cycle, CDKS and cancer: a changing paradigm. Nat Rev Cancer. 2009;9:153-66.
27. Blain SW. Switching cyclin d-cdk4 kinase activity on and off. Cell Cycle. 2008;7:892-8.
28. Sato F, Bhawal UK, Kawamoto T, Fujimoto K, Imaizumi T, Imanaka T, et al. Basic-helix-loop-helix (bhlh) transcription factor dec2 negatively regulates vascular endothelial growth factor expression. Genes Cells: Devoted Molecular Cellular Mech. 2008;13:131-44.
29. Xu Q, Ma P, Hu C, Chen L, Xue L, Wang Z, et al. Overexpression of the dec1 protein induces senescence in vitro and is related to better survival in esophageal squamous cell carcinoma. PLoS One. 2012;7:e41862.
30. Ming J, Jiang G, Zhang Q, Qiu X, Wang E. Interleukin-7 up-regulates cyclin d1 via activator protein-1 to promote proliferation of cell in lung cancer. Cancer Immunol Immunother. 2012;61:79-88.
31. Kim JK, Diehl JA. Nuclear cyclin d1: an oncogenic driver in human cancer. J Cell Physiol. 2009;220:292-6.
32. Rossner MJ, Dorr J, Gass P, Schwab MH, Nave KA. Sharps: mammalian enhancer-of-split- and hairy-related proteins coupled to neuronal stimulation. Mol Cell Neurosci. 1997;10:460-75.
33. Ivanova AV, Ivanov SV, Danilkovitch-Miagkova A, Lerman MI. Regulation of stra13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the ubc9/ubiquitin proteasome degradation pathway. J Biol Chem. 2001;276:15306-15.
34. Sun H, Lu B, Li RQ, Flavell RA, Taneja R. Defective t cell activation and autoimmune disorder in stra13-deficient mice. Nat Immunol. 2001;2:1040-7.
35. Yun Z, Maecker HL, Johnson RS, Giaccia AJ. Inhibition of PPAR gamma 2 gene expression by the hif-1-regulated gene dec1/stra13: a mechanism for regulation of adipogenesis by hypoxia. Dev Cell. 2002;2:331-41.
36. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, et al. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature. 1991;350:512-5.
37. Matsumura I, Kitamura T, Wakao H, Tanaka H, Hashimoto K, Albanese C, et al. Transcriptional regulation of the cyclin d1 promoter by stat5: its involvement in cytokine-dependent growth of hematopoietic cells. EMBO J. 1999;18:1367-77.